[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fEavo9qSJA7uLqfYGHcWIHVnQpcjn1zQ0dggoz8KYddQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":47,"rows":54},"Hvidovre University Hospital",[4],298,false,23,16,48523,2,222,[14,17,20,22,25,28,30,33],{"name":15,"count":16},"Obesity",15,{"name":18,"count":19},"Postoperative Pain",10,{"name":21,"count":19},"Type 1 Diabetes",{"name":23,"count":24},"Type 2 Diabetes",9,{"name":26,"count":27},"Hip Fracture",8,{"name":29,"count":27},"Pain, Postoperative",{"name":31,"count":32},"Cirrhosis",7,{"name":34,"count":35},"Respiratory Failure",6,[37,42],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT06234111","Semaglutide and Physical Activity for Obesity and Multimorbidity","2026-10","Semaglutide 2.4 mg, total diet replacement, behavioural intervention",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT06925997","Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery","2027-12","Colesevelam",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,104,128,175,208,253,285,336,358,380,417,453,487,509,533,551,569,592,618,645,671,697,720,738,764,782,800,822,840,858,882,908,931,949,967,992,1015,1033,1059,1082,1141,1166,1184,1212,1230,1248,1274,1300,1328,1346,1364,1389,1413,1447,1470,1488,1514,1539,1557,1575,1607,1644,1670,1703,1721,1739,1764,1790,1808,1834,1852,1870,1893,1911,1932,1955,1979,2002,2024,2049,2071,2098,2125,2143,2161,2187,2205,2223],{"intervention":46,"totalTrials":56,"cells":57},3,{"EARLY_PHASE1":58,"PHASE1":72,"PHASE2":75,"PHASE3":77,"PHASE4":79,"NA":102},{"trials":59,"activeCount":71,"soonestReadout":45},[60],{"nctId":43,"briefTitle":44,"status":61,"phases":62,"primaryCompletion":45,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":70},"RECRUITING",[48],"2028-12","2024-05-02",18,[67,68,69],"Bariatric Surgery Candidate","Bile Acid, Elevated Serum","Glucose Metabolism Disorders",[46],1,{"trials":73,"activeCount":74},[],0,{"trials":76,"activeCount":74},[],{"trials":78,"activeCount":74},[],{"trials":80,"activeCount":74},[81,93],{"nctId":82,"briefTitle":83,"status":84,"phases":85,"primaryCompletion":86,"completion":87,"start":88,"enrollment":27,"conditions":89,"interventions":91},"NCT02952963","Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass","COMPLETED",[52],"2017-12","2020-11","2016-10",[90],"Severe Obesity",[92,46],"Chenodeoxycholic Acid",{"nctId":94,"briefTitle":95,"status":84,"phases":96,"primaryCompletion":97,"completion":87,"start":98,"enrollment":99,"conditions":100,"interventions":101},"NCT02876484","Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass",[52],"2017-06","2016-06",12,[90],[46,92],{"trials":103,"activeCount":74},[],{"intervention":41,"totalTrials":71,"cells":105},{"EARLY_PHASE1":106,"PHASE1":108,"PHASE2":110,"PHASE3":112,"PHASE4":114,"NA":116},{"trials":107,"activeCount":74},[],{"trials":109,"activeCount":74},[],{"trials":111,"activeCount":74},[],{"trials":113,"activeCount":74},[],{"trials":115,"activeCount":74},[],{"trials":117,"activeCount":71,"soonestReadout":40},[118],{"nctId":38,"briefTitle":39,"status":119,"phases":120,"primaryCompletion":40,"completion":121,"start":122,"enrollment":123,"conditions":124,"interventions":127},"ACTIVE_NOT_RECRUITING",[],"2026-11","2024-02-20",35,[125,126,15],"Obesity Morbid","Multimorbidity",[41],{"intervention":129,"totalTrials":56,"cells":130},"Ropivacaine",{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":173},{"trials":132,"activeCount":74},[],{"trials":134,"activeCount":74},[],{"trials":136,"activeCount":74},[],{"trials":138,"activeCount":74},[],{"trials":140,"activeCount":74},[141,152,162],{"nctId":142,"briefTitle":143,"status":84,"phases":144,"primaryCompletion":145,"completion":145,"start":146,"enrollment":147,"conditions":148,"interventions":150},"NCT00769054","Local Infiltration Analgesia With Ropivacaine in Posterior Vaginal Wall Prolapse:a Randomized, Double-Blind Study",[52],"2009-10","2008-10",48,[149],"Vaginal Prolapse",[129,151],"Isotonic NaCl",{"nctId":153,"briefTitle":154,"status":84,"phases":155,"primaryCompletion":156,"completion":156,"start":157,"enrollment":158,"conditions":159,"interventions":161},"NCT00968955","Effect of Local Infiltration Analgesia in Total Hip Arthroplasty",[52],"2010-06","2009-09",120,[160],"Post-operative Pain",[129],{"nctId":163,"briefTitle":164,"status":84,"phases":165,"primaryCompletion":166,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":172},"NCT00891540","Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section",[52],"2010-05","2009-07",90,[29,170,171],"Postoperative Nausea and Vomiting","Cesarean Section",[129,129],{"trials":174,"activeCount":74},[],{"intervention":151,"totalTrials":56,"cells":176},{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":181,"PHASE3":183,"PHASE4":185,"NA":206},{"trials":178,"activeCount":74},[],{"trials":180,"activeCount":74},[],{"trials":182,"activeCount":74},[],{"trials":184,"activeCount":74},[],{"trials":186,"activeCount":74},[187,191,199],{"nctId":142,"briefTitle":143,"status":84,"phases":188,"primaryCompletion":145,"completion":145,"start":146,"enrollment":147,"conditions":189,"interventions":190},[52],[149],[129,151],{"nctId":192,"briefTitle":193,"status":84,"phases":194,"primaryCompletion":195,"completion":195,"start":146,"enrollment":147,"conditions":196,"interventions":197},"NCT00771459","Local Infiltration Analgesia in Major Spine Surgery With Ropivacaine Versus Placebo",[52],"2009-08",[29],[198,151],"Ropivacaine 0.5 %",{"nctId":200,"briefTitle":201,"status":84,"phases":202,"primaryCompletion":145,"completion":203,"start":146,"enrollment":147,"conditions":204,"interventions":205},"NCT00768456","Local Infiltration Analgesia With Ropivacaine Versus Placebo in Vaginal Hysterectomy: a Randomized, Double-Blind Study",[52],"2010-12",[29,170],[198,151],{"trials":207,"activeCount":74},[],{"intervention":209,"totalTrials":56,"cells":210},"Gabapentin",{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":251},{"trials":212,"activeCount":74},[],{"trials":214,"activeCount":74},[],{"trials":216,"activeCount":74},[],{"trials":218,"activeCount":74},[],{"trials":220,"activeCount":74},[221,233,243],{"nctId":222,"briefTitle":223,"status":224,"phases":225,"start":226,"enrollment":227,"conditions":228,"interventions":230},"NCT00209872","Optimal Multimodal Analgesia in Abdominal Hysterectomy","UNKNOWN",[52],"2005-10",60,[229],"Planned Abdominal Hysterectomy",[209,231,232],"Lidocaine","S-ketamine",{"nctId":234,"briefTitle":235,"status":84,"phases":236,"primaryCompletion":237,"completion":237,"start":238,"enrollment":239,"conditions":240,"interventions":242},"NCT01507363","Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)",[52],"2013-11","2012-01",300,[18,241],"Postoperative Sedation",[209,209],{"nctId":244,"briefTitle":245,"status":224,"phases":246,"start":226,"enrollment":227,"conditions":247,"interventions":249},"NCT00209885","Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy",[52],[248],"Cholecystolithiasis",[209,232,231,250],"Droperidol",{"trials":252,"activeCount":74},[],{"intervention":92,"totalTrials":56,"cells":254},{"EARLY_PHASE1":255,"PHASE1":257,"PHASE2":259,"PHASE3":261,"PHASE4":263,"NA":283},{"trials":256,"activeCount":74},[],{"trials":258,"activeCount":74},[],{"trials":260,"activeCount":74},[],{"trials":262,"activeCount":74},[],{"trials":264,"activeCount":74},[265,275,279],{"nctId":266,"briefTitle":267,"status":84,"phases":268,"primaryCompletion":269,"start":270,"enrollment":271,"conditions":272,"interventions":273},"NCT02340247","Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass",[52],"2015-04","2014-11",11,[90],[274,92],"Ursodeoxycholic Acid",{"nctId":82,"briefTitle":83,"status":84,"phases":276,"primaryCompletion":86,"completion":87,"start":88,"enrollment":27,"conditions":277,"interventions":278},[52],[90],[92,46],{"nctId":94,"briefTitle":95,"status":84,"phases":280,"primaryCompletion":97,"completion":87,"start":98,"enrollment":99,"conditions":281,"interventions":282},[52],[90],[46,92],{"trials":284,"activeCount":74},[],{"intervention":286,"totalTrials":56,"cells":287},"Adalimumab",{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":334},{"trials":289,"activeCount":74},[],{"trials":291,"activeCount":74},[],{"trials":293,"activeCount":74},[],{"trials":295,"activeCount":74},[],{"trials":297,"activeCount":74},[298,310,324],{"nctId":299,"briefTitle":300,"status":84,"phases":301,"primaryCompletion":302,"completion":302,"start":303,"enrollment":304,"conditions":305,"interventions":309},"NCT00696059","Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?",[52],"2007-07","2004-08",52,[306,307,308],"Rheumatoid Arthritis","Arthritis","Joint Diseases",[286],{"nctId":311,"briefTitle":312,"status":84,"phases":313,"completion":314,"start":315,"enrollment":316,"conditions":317,"interventions":321},"NCT00133315","TNFalfa Blocking Treatment of Spondylarthropathies",[52],"2007-04","2004-09",50,[318,319,320],"Spondylarthropathies","Ankylosing Spondylitis","Psoriatic Arthritis",[322,323,286],"Infliximab","Etanercept",{"nctId":325,"briefTitle":326,"status":224,"phases":327,"primaryCompletion":328,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":333},"NCT00216177","Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis",[52],"2009-01","2009-06","2005-09",112,[306],[322,286],{"trials":335,"activeCount":74},[],{"intervention":231,"totalTrials":11,"cells":337},{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":344,"PHASE4":346,"NA":356},{"trials":339,"activeCount":74},[],{"trials":341,"activeCount":74},[],{"trials":343,"activeCount":74},[],{"trials":345,"activeCount":74},[],{"trials":347,"activeCount":74},[348,352],{"nctId":222,"briefTitle":223,"status":224,"phases":349,"start":226,"enrollment":227,"conditions":350,"interventions":351},[52],[229],[209,231,232],{"nctId":244,"briefTitle":245,"status":224,"phases":353,"start":226,"enrollment":227,"conditions":354,"interventions":355},[52],[248],[209,232,231,250],{"trials":357,"activeCount":74},[],{"intervention":232,"totalTrials":11,"cells":359},{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":368,"NA":378},{"trials":361,"activeCount":74},[],{"trials":363,"activeCount":74},[],{"trials":365,"activeCount":74},[],{"trials":367,"activeCount":74},[],{"trials":369,"activeCount":74},[370,374],{"nctId":222,"briefTitle":223,"status":224,"phases":371,"start":226,"enrollment":227,"conditions":372,"interventions":373},[52],[229],[209,231,232],{"nctId":244,"briefTitle":245,"status":224,"phases":375,"start":226,"enrollment":227,"conditions":376,"interventions":377},[52],[248],[209,232,231,250],{"trials":379,"activeCount":74},[],{"intervention":381,"totalTrials":11,"cells":382},"Saline water",{"EARLY_PHASE1":383,"PHASE1":385,"PHASE2":387,"PHASE3":389,"PHASE4":391,"NA":415},{"trials":384,"activeCount":74},[],{"trials":386,"activeCount":74},[],{"trials":388,"activeCount":74},[],{"trials":390,"activeCount":74},[],{"trials":392,"activeCount":74},[393,405],{"nctId":394,"briefTitle":395,"status":84,"phases":396,"primaryCompletion":397,"completion":397,"start":398,"enrollment":227,"conditions":399,"interventions":403},"NCT02427412","Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty",[52],"2015-05","2014-01",[400,401,402],"Blood Loss","Postoperative Blood Loss","Thromboembolic Complications",[404,381,404],"Tranexamic Acid",{"nctId":406,"briefTitle":407,"status":84,"phases":408,"primaryCompletion":409,"completion":410,"start":411,"enrollment":147,"conditions":412,"interventions":413},"NCT01472913","Fibrin Sealant in Bilateral Simultaneous Total Knee Arthroplasty With Focus on Blood Loss, Pain, Swelling and Strength",[52],"2013-08","2013-09","2010-08",[400],[414,381],"Fibrin sealant",{"trials":416,"activeCount":74},[],{"intervention":418,"totalTrials":11,"cells":419},"propranolol",{"EARLY_PHASE1":420,"PHASE1":422,"PHASE2":424,"PHASE3":426,"PHASE4":438,"NA":451},{"trials":421,"activeCount":74},[],{"trials":423,"activeCount":74},[],{"trials":425,"activeCount":74},[],{"trials":427,"activeCount":74},[428],{"nctId":429,"briefTitle":430,"status":84,"phases":431,"primaryCompletion":195,"completion":195,"start":432,"enrollment":433,"conditions":434,"interventions":436},"NCT00493480","Danish Carvedilol Study in Portal Hypertension",[51],"2003-09",40,[31,435],"Portal Hypertension",[437,418],"carvedilol",{"trials":439,"activeCount":74},[440],{"nctId":441,"briefTitle":442,"status":224,"phases":443,"primaryCompletion":444,"completion":203,"start":445,"enrollment":446,"conditions":447,"interventions":449},"NCT00332904","Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis",[52],"2008-07","2006-08",22,[448,435],"Liver Cirrhosis",[418,450],"spironolactone",{"trials":452,"activeCount":74},[],{"intervention":454,"totalTrials":11,"cells":455},"Methylprednisolone",{"EARLY_PHASE1":456,"PHASE1":458,"PHASE2":460,"PHASE3":462,"PHASE4":464,"NA":485},{"trials":457,"activeCount":74},[],{"trials":459,"activeCount":74},[],{"trials":461,"activeCount":74},[],{"trials":463,"activeCount":74},[],{"trials":465,"activeCount":74},[466,478],{"nctId":467,"briefTitle":468,"status":84,"phases":469,"primaryCompletion":470,"completion":470,"start":471,"enrollment":147,"conditions":472,"interventions":477},"NCT00968903","Effects of Methylprednisolone After Total Hip Arthroplasty",[52],"2011-01","2010-04",[473,18,170,474,475,476],"LOS","Sleeping Quality","Fatigue","Inflammatory Response",[454],{"nctId":479,"briefTitle":480,"status":84,"phases":481,"primaryCompletion":482,"completion":482,"start":195,"enrollment":147,"conditions":483,"interventions":484},"NCT00968578","Effects of Methylprednisolone After Total Knee Arthroplasty",[52],"2009-12",[18,170,474,475,476],[454],{"trials":486,"activeCount":74},[],{"intervention":198,"totalTrials":11,"cells":488},{"EARLY_PHASE1":489,"PHASE1":491,"PHASE2":493,"PHASE3":495,"PHASE4":497,"NA":507},{"trials":490,"activeCount":74},[],{"trials":492,"activeCount":74},[],{"trials":494,"activeCount":74},[],{"trials":496,"activeCount":74},[],{"trials":498,"activeCount":74},[499,503],{"nctId":192,"briefTitle":193,"status":84,"phases":500,"primaryCompletion":195,"completion":195,"start":146,"enrollment":147,"conditions":501,"interventions":502},[52],[29],[198,151],{"nctId":200,"briefTitle":201,"status":84,"phases":504,"primaryCompletion":145,"completion":203,"start":146,"enrollment":147,"conditions":505,"interventions":506},[52],[29,170],[198,151],{"trials":508,"activeCount":74},[],{"intervention":510,"totalTrials":71,"cells":511},"Escitalopram",{"EARLY_PHASE1":512,"PHASE1":514,"PHASE2":516,"PHASE3":518,"PHASE4":520,"NA":531},{"trials":513,"activeCount":74},[],{"trials":515,"activeCount":74},[],{"trials":517,"activeCount":74},[],{"trials":519,"activeCount":74},[],{"trials":521,"activeCount":74},[522],{"nctId":523,"briefTitle":524,"status":84,"phases":525,"primaryCompletion":526,"completion":527,"start":528,"enrollment":158,"conditions":529,"interventions":530},"NCT01430520","Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)",[52],"2013-04","2013-05","2011-09",[18],[510],{"trials":532,"activeCount":74},[],{"intervention":274,"totalTrials":71,"cells":534},{"EARLY_PHASE1":535,"PHASE1":537,"PHASE2":539,"PHASE3":541,"PHASE4":543,"NA":549},{"trials":536,"activeCount":74},[],{"trials":538,"activeCount":74},[],{"trials":540,"activeCount":74},[],{"trials":542,"activeCount":74},[],{"trials":544,"activeCount":74},[545],{"nctId":266,"briefTitle":267,"status":84,"phases":546,"primaryCompletion":269,"start":270,"enrollment":271,"conditions":547,"interventions":548},[52],[90],[274,92],{"trials":550,"activeCount":74},[],{"intervention":414,"totalTrials":71,"cells":552},{"EARLY_PHASE1":553,"PHASE1":555,"PHASE2":557,"PHASE3":559,"PHASE4":561,"NA":567},{"trials":554,"activeCount":74},[],{"trials":556,"activeCount":74},[],{"trials":558,"activeCount":74},[],{"trials":560,"activeCount":74},[],{"trials":562,"activeCount":74},[563],{"nctId":406,"briefTitle":407,"status":84,"phases":564,"primaryCompletion":409,"completion":410,"start":411,"enrollment":147,"conditions":565,"interventions":566},[52],[400],[414,381],{"trials":568,"activeCount":74},[],{"intervention":570,"totalTrials":71,"cells":571},"Red blood cell transfusion",{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":580,"NA":590},{"trials":573,"activeCount":74},[],{"trials":575,"activeCount":74},[],{"trials":577,"activeCount":74},[],{"trials":579,"activeCount":74},[],{"trials":581,"activeCount":74},[582],{"nctId":583,"briefTitle":584,"status":224,"phases":585,"completion":586,"start":587,"enrollment":158,"conditions":588,"interventions":589},"NCT00162617","The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture Surgery",[52],"2006-03","2004-01",[26],[570],{"trials":591,"activeCount":74},[],{"intervention":593,"totalTrials":71,"cells":594},"methylprednisolone sodium succinate",{"EARLY_PHASE1":595,"PHASE1":597,"PHASE2":599,"PHASE3":601,"PHASE4":603,"NA":616},{"trials":596,"activeCount":74},[],{"trials":598,"activeCount":74},[],{"trials":600,"activeCount":74},[],{"trials":602,"activeCount":74},[],{"trials":604,"activeCount":74},[605],{"nctId":606,"briefTitle":607,"status":84,"phases":608,"primaryCompletion":609,"completion":609,"start":610,"enrollment":611,"conditions":612,"interventions":615},"NCT02317601","Preoperative Single Glucocorticoid Hip Fracture Hip Fracture Surgery",[52],"2016-05","2014-12",122,[613,614],"Delirium - Postoperative","Stress, Physiological",[593],{"trials":617,"activeCount":74},[],{"intervention":619,"totalTrials":71,"cells":620},"Doptelet Pill",{"EARLY_PHASE1":621,"PHASE1":623,"PHASE2":625,"PHASE3":627,"PHASE4":629,"NA":643},{"trials":622,"activeCount":74},[],{"trials":624,"activeCount":74},[],{"trials":626,"activeCount":74},[],{"trials":628,"activeCount":74},[],{"trials":630,"activeCount":74},[631],{"nctId":632,"briefTitle":633,"status":224,"phases":634,"primaryCompletion":635,"completion":635,"start":636,"enrollment":637,"conditions":638,"interventions":642},"NCT04845659","Avatrombopaq In Patients With Cirrhosis",[52],"2022-06-01","2021-06-01",20,[639,640,641],"Thrombocytopenia; Drugs","Cirrhosis, Liver","Procedural Bleeding",[619],{"trials":644,"activeCount":74},[],{"intervention":646,"totalTrials":71,"cells":647},"Montelukast",{"EARLY_PHASE1":648,"PHASE1":650,"PHASE2":652,"PHASE3":654,"PHASE4":656,"NA":669},{"trials":649,"activeCount":74},[],{"trials":651,"activeCount":74},[],{"trials":653,"activeCount":74},[],{"trials":655,"activeCount":74},[],{"trials":657,"activeCount":74},[658],{"nctId":659,"briefTitle":660,"status":84,"phases":661,"primaryCompletion":662,"completion":663,"start":664,"enrollment":665,"conditions":666,"interventions":668},"NCT00913328","Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness",[52],"2006-05","2006-10","2002-08",31,[667],"Asthma",[646],{"trials":670,"activeCount":74},[],{"intervention":672,"totalTrials":71,"cells":673},"Genotropin",{"EARLY_PHASE1":674,"PHASE1":676,"PHASE2":678,"PHASE3":680,"PHASE4":682,"NA":695},{"trials":675,"activeCount":74},[],{"trials":677,"activeCount":74},[],{"trials":679,"activeCount":74},[],{"trials":681,"activeCount":74},[],{"trials":683,"activeCount":74},[684],{"nctId":685,"briefTitle":686,"status":84,"phases":687,"primaryCompletion":688,"completion":444,"start":689,"enrollment":690,"conditions":691,"interventions":694},"NCT00119769","The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients",[52],"2007-05","2005-02",46,[692,693],"HIV Infections","Lipodystrophy",[672],{"trials":696,"activeCount":74},[],{"intervention":698,"totalTrials":71,"cells":699},"ropivacaine 0.2%, 50 mL",{"EARLY_PHASE1":700,"PHASE1":702,"PHASE2":704,"PHASE3":706,"PHASE4":708,"NA":718},{"trials":701,"activeCount":74},[],{"trials":703,"activeCount":74},[],{"trials":705,"activeCount":74},[],{"trials":707,"activeCount":74},[],{"trials":709,"activeCount":74},[710],{"nctId":711,"briefTitle":712,"status":84,"phases":713,"primaryCompletion":329,"completion":329,"start":714,"enrollment":9,"conditions":715,"interventions":716},"NCT00927225","Local Infiltration Analgesia in Bilateral Knee Arthroplasty - Efficacy of Subcutaneous Wound Infiltration With Local Anesthetic",[52],"2008-09",[29],[698,717],"normal saline",{"trials":719,"activeCount":74},[],{"intervention":717,"totalTrials":71,"cells":721},{"EARLY_PHASE1":722,"PHASE1":724,"PHASE2":726,"PHASE3":728,"PHASE4":730,"NA":736},{"trials":723,"activeCount":74},[],{"trials":725,"activeCount":74},[],{"trials":727,"activeCount":74},[],{"trials":729,"activeCount":74},[],{"trials":731,"activeCount":74},[732],{"nctId":711,"briefTitle":712,"status":84,"phases":733,"primaryCompletion":329,"completion":329,"start":714,"enrollment":9,"conditions":734,"interventions":735},[52],[29],[698,717],{"trials":737,"activeCount":74},[],{"intervention":739,"totalTrials":71,"cells":740},"Methotrexate",{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":747,"PHASE4":749,"NA":762},{"trials":742,"activeCount":74},[],{"trials":744,"activeCount":74},[],{"trials":746,"activeCount":74},[],{"trials":748,"activeCount":74},[],{"trials":750,"activeCount":74},[751],{"nctId":752,"briefTitle":753,"status":84,"phases":754,"completion":755,"start":756,"enrollment":757,"conditions":758,"interventions":759},"NCT00209859","Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis",[52],"2007-11","1998-10",160,[306],[739,760,761],"Intraarticular betamethasone","Cyclosporine\u002Fplacebo-cyclosporine",{"trials":763,"activeCount":74},[],{"intervention":760,"totalTrials":71,"cells":765},{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":772,"PHASE4":774,"NA":780},{"trials":767,"activeCount":74},[],{"trials":769,"activeCount":74},[],{"trials":771,"activeCount":74},[],{"trials":773,"activeCount":74},[],{"trials":775,"activeCount":74},[776],{"nctId":752,"briefTitle":753,"status":84,"phases":777,"completion":755,"start":756,"enrollment":757,"conditions":778,"interventions":779},[52],[306],[739,760,761],{"trials":781,"activeCount":74},[],{"intervention":761,"totalTrials":71,"cells":783},{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":790,"PHASE4":792,"NA":798},{"trials":785,"activeCount":74},[],{"trials":787,"activeCount":74},[],{"trials":789,"activeCount":74},[],{"trials":791,"activeCount":74},[],{"trials":793,"activeCount":74},[794],{"nctId":752,"briefTitle":753,"status":84,"phases":795,"completion":755,"start":756,"enrollment":757,"conditions":796,"interventions":797},[52],[306],[739,760,761],{"trials":799,"activeCount":74},[],{"intervention":801,"totalTrials":71,"cells":802},"Tapering of inhaled corticosteroid (ICS) treatment",{"EARLY_PHASE1":803,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":811,"NA":820},{"trials":804,"activeCount":74},[],{"trials":806,"activeCount":74},[],{"trials":808,"activeCount":74},[],{"trials":810,"activeCount":74},[],{"trials":812,"activeCount":74},[813],{"nctId":814,"briefTitle":815,"status":84,"phases":816,"primaryCompletion":817,"completion":817,"start":635,"enrollment":637,"conditions":818,"interventions":819},"NCT03141424","Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma",[52],"2024-10-25",[667],[801],{"trials":821,"activeCount":74},[],{"intervention":250,"totalTrials":71,"cells":823},{"EARLY_PHASE1":824,"PHASE1":826,"PHASE2":828,"PHASE3":830,"PHASE4":832,"NA":838},{"trials":825,"activeCount":74},[],{"trials":827,"activeCount":74},[],{"trials":829,"activeCount":74},[],{"trials":831,"activeCount":74},[],{"trials":833,"activeCount":74},[834],{"nctId":244,"briefTitle":245,"status":224,"phases":835,"start":226,"enrollment":227,"conditions":836,"interventions":837},[52],[248],[209,232,231,250],{"trials":839,"activeCount":74},[],{"intervention":450,"totalTrials":71,"cells":841},{"EARLY_PHASE1":842,"PHASE1":844,"PHASE2":846,"PHASE3":848,"PHASE4":850,"NA":856},{"trials":843,"activeCount":74},[],{"trials":845,"activeCount":74},[],{"trials":847,"activeCount":74},[],{"trials":849,"activeCount":74},[],{"trials":851,"activeCount":74},[852],{"nctId":441,"briefTitle":442,"status":224,"phases":853,"primaryCompletion":444,"completion":203,"start":445,"enrollment":446,"conditions":854,"interventions":855},[52],[448,435],[418,450],{"trials":857,"activeCount":74},[],{"intervention":859,"totalTrials":71,"cells":860},"Ciprofloxacin",{"EARLY_PHASE1":861,"PHASE1":863,"PHASE2":865,"PHASE3":867,"PHASE4":869,"NA":880},{"trials":862,"activeCount":74},[],{"trials":864,"activeCount":74},[],{"trials":866,"activeCount":74},[],{"trials":868,"activeCount":74},[],{"trials":870,"activeCount":74},[871],{"nctId":872,"briefTitle":873,"status":84,"phases":874,"primaryCompletion":409,"completion":409,"start":875,"enrollment":876,"conditions":877,"interventions":879},"NCT01772615","Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle",[52],"2011-05",100,[878],"Ulcerative Colitis",[859],{"trials":881,"activeCount":74},[],{"intervention":883,"totalTrials":71,"cells":884},"Zolpidem",{"EARLY_PHASE1":885,"PHASE1":887,"PHASE2":889,"PHASE3":891,"PHASE4":893,"NA":906},{"trials":886,"activeCount":74},[],{"trials":888,"activeCount":74},[],{"trials":890,"activeCount":74},[],{"trials":892,"activeCount":74},[],{"trials":894,"activeCount":74},[895],{"nctId":896,"briefTitle":897,"status":898,"phases":899,"completion":900,"start":901,"enrollment":902,"conditions":903,"interventions":905},"NCT00286936","Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo","TERMINATED",[52],"2007-01","2004-02",96,[26,904],"Delirium",[883],{"trials":907,"activeCount":74},[],{"intervention":909,"totalTrials":71,"cells":910},"intraarticular injection with ropivacaine",{"EARLY_PHASE1":911,"PHASE1":913,"PHASE2":915,"PHASE3":917,"PHASE4":919,"NA":929},{"trials":912,"activeCount":74},[],{"trials":914,"activeCount":74},[],{"trials":916,"activeCount":74},[],{"trials":918,"activeCount":74},[],{"trials":920,"activeCount":74},[921],{"nctId":922,"briefTitle":923,"status":224,"phases":924,"primaryCompletion":444,"completion":444,"start":925,"enrollment":227,"conditions":926,"interventions":927},"NCT00632580","Intra- Versus Extraarticular Injection of Ropivacaine in Total Knee Arthroplasty",[52],"2008-01",[29],[909,928],"extraarticular injection with ropivacaine",{"trials":930,"activeCount":74},[],{"intervention":928,"totalTrials":71,"cells":932},{"EARLY_PHASE1":933,"PHASE1":935,"PHASE2":937,"PHASE3":939,"PHASE4":941,"NA":947},{"trials":934,"activeCount":74},[],{"trials":936,"activeCount":74},[],{"trials":938,"activeCount":74},[],{"trials":940,"activeCount":74},[],{"trials":942,"activeCount":74},[943],{"nctId":922,"briefTitle":923,"status":224,"phases":944,"primaryCompletion":444,"completion":444,"start":925,"enrollment":227,"conditions":945,"interventions":946},[52],[29],[909,928],{"trials":948,"activeCount":74},[],{"intervention":323,"totalTrials":71,"cells":950},{"EARLY_PHASE1":951,"PHASE1":953,"PHASE2":955,"PHASE3":957,"PHASE4":959,"NA":965},{"trials":952,"activeCount":74},[],{"trials":954,"activeCount":74},[],{"trials":956,"activeCount":74},[],{"trials":958,"activeCount":74},[],{"trials":960,"activeCount":74},[961],{"nctId":311,"briefTitle":312,"status":84,"phases":962,"completion":314,"start":315,"enrollment":316,"conditions":963,"interventions":964},[52],[318,319,320],[322,323,286],{"trials":966,"activeCount":74},[],{"intervention":968,"totalTrials":71,"cells":969},"Glucagon",{"EARLY_PHASE1":970,"PHASE1":972,"PHASE2":974,"PHASE3":976,"PHASE4":978,"NA":990},{"trials":971,"activeCount":74},[],{"trials":973,"activeCount":74},[],{"trials":975,"activeCount":74},[],{"trials":977,"activeCount":74},[],{"trials":979,"activeCount":74},[980],{"nctId":981,"briefTitle":982,"status":224,"phases":983,"primaryCompletion":984,"completion":985,"start":986,"enrollment":27,"conditions":987,"interventions":989},"NCT02232971","Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes",[52],"2015-01","2015-07","2014-09",[988],"Diabetes Mellitus, Type 1",[968],{"trials":991,"activeCount":74},[],{"intervention":993,"totalTrials":71,"cells":994},"ropivacaine 0,2%",{"EARLY_PHASE1":995,"PHASE1":997,"PHASE2":999,"PHASE3":1001,"PHASE4":1003,"NA":1013},{"trials":996,"activeCount":74},[],{"trials":998,"activeCount":74},[],{"trials":1000,"activeCount":74},[],{"trials":1002,"activeCount":74},[],{"trials":1004,"activeCount":74},[1005],{"nctId":1006,"briefTitle":1007,"status":224,"phases":1008,"enrollment":99,"conditions":1009,"interventions":1011},"NCT00864409","Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty",[52],[18,1010],"Hip Arthroplasty",[993,1012],"saline.9%",{"trials":1014,"activeCount":74},[],{"intervention":1012,"totalTrials":71,"cells":1016},{"EARLY_PHASE1":1017,"PHASE1":1019,"PHASE2":1021,"PHASE3":1023,"PHASE4":1025,"NA":1031},{"trials":1018,"activeCount":74},[],{"trials":1020,"activeCount":74},[],{"trials":1022,"activeCount":74},[],{"trials":1024,"activeCount":74},[],{"trials":1026,"activeCount":74},[1027],{"nctId":1006,"briefTitle":1007,"status":224,"phases":1028,"enrollment":99,"conditions":1029,"interventions":1030},[52],[18,1010],[993,1012],{"trials":1032,"activeCount":74},[],{"intervention":1034,"totalTrials":71,"cells":1035},"1-84 parathyroid hormone",{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1040,"PHASE3":1042,"PHASE4":1044,"NA":1057},{"trials":1037,"activeCount":74},[],{"trials":1039,"activeCount":74},[],{"trials":1041,"activeCount":74},[],{"trials":1043,"activeCount":74},[],{"trials":1045,"activeCount":74},[1046],{"nctId":1047,"briefTitle":1048,"status":224,"phases":1049,"primaryCompletion":1050,"completion":1051,"start":1052,"enrollment":1053,"conditions":1054,"interventions":1056},"NCT01687374","Parathyroid Hormone for the Treatment of Humerus Fractures",[52],"2012-12","2013-12","2012-03",72,[1055],"Shoulder Fractures",[1034],{"trials":1058,"activeCount":74},[],{"intervention":1060,"totalTrials":71,"cells":1061},"Magnesia",{"EARLY_PHASE1":1062,"PHASE1":1064,"PHASE2":1066,"PHASE3":1068,"PHASE4":1070,"NA":1080},{"trials":1063,"activeCount":74},[],{"trials":1065,"activeCount":74},[],{"trials":1067,"activeCount":74},[],{"trials":1069,"activeCount":74},[],{"trials":1071,"activeCount":74},[1072],{"nctId":1073,"briefTitle":1074,"status":84,"phases":1075,"primaryCompletion":328,"completion":328,"start":900,"enrollment":1076,"conditions":1077,"interventions":1079},"NCT00427492","Effect of Postoperative Laxative on Bowel Function After Colonic Surgery",[52],56,[1078],"Colonic Cancer",[1060],{"trials":1081,"activeCount":74},[],{"intervention":1083,"totalTrials":1084,"cells":1085},"Liraglutide",5,{"EARLY_PHASE1":1086,"PHASE1":1088,"PHASE2":1090,"PHASE3":1092,"PHASE4":1137,"NA":1139},{"trials":1087,"activeCount":74},[],{"trials":1089,"activeCount":74},[],{"trials":1091,"activeCount":74},[],{"trials":1093,"activeCount":74},[1094,1103,1111,1120,1129],{"nctId":1095,"briefTitle":1096,"status":84,"phases":1097,"primaryCompletion":1098,"completion":1098,"start":1099,"enrollment":433,"conditions":1100,"interventions":1102},"NCT02092896","Liraglutide as add-on to Insulin in Type 1 Diabetes",[51],"2014-10","2013-03",[1101,988],"Diabetes",[1083,1083],{"nctId":1104,"briefTitle":1105,"status":84,"phases":1106,"primaryCompletion":88,"completion":88,"start":1107,"enrollment":1108,"conditions":1109,"interventions":1110},"NCT02351232","The Lira Pump Trial",[50,51],"2015-02",44,[21],[1083],{"nctId":1112,"briefTitle":1113,"status":84,"phases":1114,"primaryCompletion":1115,"completion":1115,"start":1116,"enrollment":1117,"conditions":1118,"interventions":1119},"NCT01879917","Liraglutide in Newly Onset Type 1 Diabetes.",[50,51],"2018-08","2014-02",65,[988],[1083],{"nctId":1121,"briefTitle":1122,"status":84,"phases":1123,"primaryCompletion":1124,"completion":1124,"start":145,"enrollment":1125,"conditions":1126,"interventions":1128},"NCT00993720","Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes",[50,51],"2010-10",30,[1127],"Diabetes Mellitus",[1083,1083],{"nctId":1130,"briefTitle":1131,"status":224,"phases":1132,"primaryCompletion":1133,"start":985,"enrollment":19,"conditions":1134,"interventions":1135},"NCT02584582","The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate",[50,51],"2015-11",[21],[1083,1136],"Exenatide",{"trials":1138,"activeCount":74},[],{"trials":1140,"activeCount":74},[],{"intervention":1142,"totalTrials":71,"cells":1143},"Magnesium sulphate",{"EARLY_PHASE1":1144,"PHASE1":1146,"PHASE2":1148,"PHASE3":1150,"PHASE4":1162,"NA":1164},{"trials":1145,"activeCount":74},[],{"trials":1147,"activeCount":74},[],{"trials":1149,"activeCount":74},[],{"trials":1151,"activeCount":74},[1152],{"nctId":1153,"briefTitle":1154,"status":84,"phases":1155,"primaryCompletion":1156,"completion":1156,"start":1157,"enrollment":1158,"conditions":1159,"interventions":1161},"NCT01492608","Magnesium Sulphate for Preterm Birth (MASP Study)",[51],"2019-08-12","2011-12-16",560,[1160],"Cerebral Palsy",[1142],{"trials":1163,"activeCount":74},[],{"trials":1165,"activeCount":74},[],{"intervention":437,"totalTrials":71,"cells":1167},{"EARLY_PHASE1":1168,"PHASE1":1170,"PHASE2":1172,"PHASE3":1174,"PHASE4":1180,"NA":1182},{"trials":1169,"activeCount":74},[],{"trials":1171,"activeCount":74},[],{"trials":1173,"activeCount":74},[],{"trials":1175,"activeCount":74},[1176],{"nctId":429,"briefTitle":430,"status":84,"phases":1177,"primaryCompletion":195,"completion":195,"start":432,"enrollment":433,"conditions":1178,"interventions":1179},[51],[31,435],[437,418],{"trials":1181,"activeCount":74},[],{"trials":1183,"activeCount":74},[],{"intervention":1185,"totalTrials":71,"cells":1186},"Vancomycin",{"EARLY_PHASE1":1187,"PHASE1":1189,"PHASE2":1191,"PHASE3":1193,"PHASE4":1208,"NA":1210},{"trials":1188,"activeCount":74},[],{"trials":1190,"activeCount":74},[],{"trials":1192,"activeCount":74},[],{"trials":1194,"activeCount":74},[1195],{"nctId":1196,"briefTitle":1197,"status":224,"phases":1198,"primaryCompletion":1199,"completion":1200,"start":1201,"enrollment":1202,"conditions":1203,"interventions":1205},"NCT02774382","Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections",[51],"2018-12","2019-01","2017-05-01",450,[1204],"Clostridium Difficile",[1185,1206,1207],"Fecal microbiota transplantation","Rectal bacteriotherapy",{"trials":1209,"activeCount":74},[],{"trials":1211,"activeCount":74},[],{"intervention":1206,"totalTrials":71,"cells":1213},{"EARLY_PHASE1":1214,"PHASE1":1216,"PHASE2":1218,"PHASE3":1220,"PHASE4":1226,"NA":1228},{"trials":1215,"activeCount":74},[],{"trials":1217,"activeCount":74},[],{"trials":1219,"activeCount":74},[],{"trials":1221,"activeCount":74},[1222],{"nctId":1196,"briefTitle":1197,"status":224,"phases":1223,"primaryCompletion":1199,"completion":1200,"start":1201,"enrollment":1202,"conditions":1224,"interventions":1225},[51],[1204],[1185,1206,1207],{"trials":1227,"activeCount":74},[],{"trials":1229,"activeCount":74},[],{"intervention":1207,"totalTrials":71,"cells":1231},{"EARLY_PHASE1":1232,"PHASE1":1234,"PHASE2":1236,"PHASE3":1238,"PHASE4":1244,"NA":1246},{"trials":1233,"activeCount":74},[],{"trials":1235,"activeCount":74},[],{"trials":1237,"activeCount":74},[],{"trials":1239,"activeCount":74},[1240],{"nctId":1196,"briefTitle":1197,"status":224,"phases":1241,"primaryCompletion":1199,"completion":1200,"start":1201,"enrollment":1202,"conditions":1242,"interventions":1243},[51],[1204],[1185,1206,1207],{"trials":1245,"activeCount":74},[],{"trials":1247,"activeCount":74},[],{"intervention":1249,"totalTrials":71,"cells":1250},"Clindamycin",{"EARLY_PHASE1":1251,"PHASE1":1253,"PHASE2":1255,"PHASE3":1257,"PHASE4":1270,"NA":1272},{"trials":1252,"activeCount":74},[],{"trials":1254,"activeCount":74},[],{"trials":1256,"activeCount":74},[],{"trials":1258,"activeCount":74},[1259],{"nctId":1260,"briefTitle":1261,"status":84,"phases":1262,"primaryCompletion":1263,"completion":1263,"start":1264,"enrollment":1265,"conditions":1266,"interventions":1269},"NCT04104178","Optimal Treatment of MRSA Throat Carriers",[51],"2025-09-18","2020-05-20",53,[1267,1268],"MRSA","MRSA Colonization",[1249],{"trials":1271,"activeCount":74},[],{"trials":1273,"activeCount":74},[],{"intervention":1275,"totalTrials":71,"cells":1276},"chlordiazepoxide",{"EARLY_PHASE1":1277,"PHASE1":1279,"PHASE2":1281,"PHASE3":1283,"PHASE4":1296,"NA":1298},{"trials":1278,"activeCount":74},[],{"trials":1280,"activeCount":74},[],{"trials":1282,"activeCount":74},[],{"trials":1284,"activeCount":74},[1285],{"nctId":1286,"briefTitle":1287,"status":84,"phases":1288,"primaryCompletion":1289,"completion":714,"start":1290,"enrollment":1291,"conditions":1292,"interventions":1295},"NCT00136617","Outpatient Treatment of Alcohol Withdrawal Syndrome",[51],"2006-07","2003-08",165,[1293,1294],"Alcoholism","Alcohol Withdrawal",[1275],{"trials":1297,"activeCount":74},[],{"trials":1299,"activeCount":74},[],{"intervention":1301,"totalTrials":71,"cells":1302},"Azathioprine and Allopurinol",{"EARLY_PHASE1":1303,"PHASE1":1305,"PHASE2":1307,"PHASE3":1309,"PHASE4":1324,"NA":1326},{"trials":1304,"activeCount":74},[],{"trials":1306,"activeCount":74},[],{"trials":1308,"activeCount":74},[],{"trials":1310,"activeCount":74},[1311],{"nctId":1312,"briefTitle":1313,"status":224,"phases":1314,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":1318,"conditions":1319,"interventions":1322},"NCT03101800","Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis",[51],"2019-11-14","2019-12-14","2016-12-14",84,[1320,1321],"Colitis, Ulcerative","Colitis Ulcerative Exacerbation",[1301,1323],"Azathioprine",{"trials":1325,"activeCount":74},[],{"trials":1327,"activeCount":74},[],{"intervention":1323,"totalTrials":71,"cells":1329},{"EARLY_PHASE1":1330,"PHASE1":1332,"PHASE2":1334,"PHASE3":1336,"PHASE4":1342,"NA":1344},{"trials":1331,"activeCount":74},[],{"trials":1333,"activeCount":74},[],{"trials":1335,"activeCount":74},[],{"trials":1337,"activeCount":74},[1338],{"nctId":1312,"briefTitle":1313,"status":224,"phases":1339,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":1318,"conditions":1340,"interventions":1341},[51],[1320,1321],[1301,1323],{"trials":1343,"activeCount":74},[],{"trials":1345,"activeCount":74},[],{"intervention":1136,"totalTrials":71,"cells":1347},{"EARLY_PHASE1":1348,"PHASE1":1350,"PHASE2":1352,"PHASE3":1354,"PHASE4":1360,"NA":1362},{"trials":1349,"activeCount":74},[],{"trials":1351,"activeCount":74},[],{"trials":1353,"activeCount":74},[],{"trials":1355,"activeCount":74},[1356],{"nctId":1130,"briefTitle":1131,"status":224,"phases":1357,"primaryCompletion":1133,"start":985,"enrollment":19,"conditions":1358,"interventions":1359},[50,51],[21],[1083,1136],{"trials":1361,"activeCount":74},[],{"trials":1363,"activeCount":74},[],{"intervention":1365,"totalTrials":71,"cells":1366},"glyceryl nitrate",{"EARLY_PHASE1":1367,"PHASE1":1369,"PHASE2":1371,"PHASE3":1373,"PHASE4":1385,"NA":1387},{"trials":1368,"activeCount":74},[],{"trials":1370,"activeCount":74},[],{"trials":1372,"activeCount":74},[],{"trials":1374,"activeCount":74},[1375],{"nctId":1376,"briefTitle":1377,"status":84,"phases":1378,"completion":1379,"start":1380,"enrollment":1381,"conditions":1382,"interventions":1384},"NCT00121901","Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?",[51],"2007-10","2004-10",1600,[1383],"Pancreatitis",[1365],{"trials":1386,"activeCount":74},[],{"trials":1388,"activeCount":74},[],{"intervention":1390,"totalTrials":71,"cells":1391},"Terlipressin",{"EARLY_PHASE1":1392,"PHASE1":1394,"PHASE2":1396,"PHASE3":1398,"PHASE4":1409,"NA":1411},{"trials":1393,"activeCount":74},[],{"trials":1395,"activeCount":74},[],{"trials":1397,"activeCount":74},[],{"trials":1399,"activeCount":74},[1400],{"nctId":1401,"briefTitle":1402,"status":84,"phases":1403,"completion":1404,"start":1405,"conditions":1406,"interventions":1408},"NCT00115947","Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites",[50,51],"2006-01","2004-12",[31,1407],"Ascites",[1390],{"trials":1410,"activeCount":74},[],{"trials":1412,"activeCount":74},[],{"intervention":1414,"totalTrials":11,"cells":1415},"Bupivacaine",{"EARLY_PHASE1":1416,"PHASE1":1418,"PHASE2":1420,"PHASE3":1441,"PHASE4":1443,"NA":1445},{"trials":1417,"activeCount":74},[],{"trials":1419,"activeCount":74},[],{"trials":1421,"activeCount":74},[1422,1431],{"nctId":1423,"briefTitle":1424,"status":898,"phases":1425,"primaryCompletion":398,"completion":1426,"start":1427,"enrollment":665,"conditions":1428,"interventions":1430},"NCT01584947","Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain",[50],"2014-08","2012-04",[1429],"Chronic Pain",[1414],{"nctId":1432,"briefTitle":1433,"status":84,"phases":1434,"primaryCompletion":1435,"completion":1435,"start":986,"enrollment":1436,"conditions":1437,"interventions":1439},"NCT02252926","Local Anesthetic Treatment of Oral Pain in Patients With Mucositis",[50],"2015-12",70,[1438],"Mucositis",[1414,1440],"Standard treatment",{"trials":1442,"activeCount":74},[],{"trials":1444,"activeCount":74},[],{"trials":1446,"activeCount":74},[],{"intervention":1448,"totalTrials":71,"cells":1449},"lactobacilus acidophilus & bifidobacterium animalis\u002Flactis",{"EARLY_PHASE1":1450,"PHASE1":1452,"PHASE2":1454,"PHASE3":1464,"PHASE4":1466,"NA":1468},{"trials":1451,"activeCount":74},[],{"trials":1453,"activeCount":74},[],{"trials":1455,"activeCount":74},[1456],{"nctId":1457,"briefTitle":1458,"status":898,"phases":1459,"primaryCompletion":1460,"completion":1460,"start":1461,"enrollment":147,"conditions":1462,"interventions":1463},"NCT00268164","Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis",[50],"2007-03","2004-06",[878],[1448],{"trials":1465,"activeCount":74},[],{"trials":1467,"activeCount":74},[],{"trials":1469,"activeCount":74},[],{"intervention":1440,"totalTrials":71,"cells":1471},{"EARLY_PHASE1":1472,"PHASE1":1474,"PHASE2":1476,"PHASE3":1482,"PHASE4":1484,"NA":1486},{"trials":1473,"activeCount":74},[],{"trials":1475,"activeCount":74},[],{"trials":1477,"activeCount":74},[1478],{"nctId":1432,"briefTitle":1433,"status":84,"phases":1479,"primaryCompletion":1435,"completion":1435,"start":986,"enrollment":1436,"conditions":1480,"interventions":1481},[50],[1438],[1414,1440],{"trials":1483,"activeCount":74},[],{"trials":1485,"activeCount":74},[],{"trials":1487,"activeCount":74},[],{"intervention":1489,"totalTrials":71,"cells":1490},"Fecal Microbiome Transplant",{"EARLY_PHASE1":1491,"PHASE1":1504,"PHASE2":1506,"PHASE3":1508,"PHASE4":1510,"NA":1512},{"trials":1492,"activeCount":74},[1493],{"nctId":1494,"briefTitle":1495,"status":84,"phases":1496,"primaryCompletion":1497,"completion":1497,"start":1498,"enrollment":1499,"conditions":1500,"interventions":1503},"NCT05834010","Feasibility Study of Using Fecal Microbiota Transplants in Anorexia Nervosa",[48],"2025-01-01","2023-03-18",17,[1501,1502],"Anorexia Nervosa","Microbiome Dysbiosis",[1489],{"trials":1505,"activeCount":74},[],{"trials":1507,"activeCount":74},[],{"trials":1509,"activeCount":74},[],{"trials":1511,"activeCount":74},[],{"trials":1513,"activeCount":74},[],{"intervention":1515,"totalTrials":71,"cells":1516},"PYY1-36",{"EARLY_PHASE1":1517,"PHASE1":1529,"PHASE2":1531,"PHASE3":1533,"PHASE4":1535,"NA":1537},{"trials":1518,"activeCount":74},[1519],{"nctId":1520,"briefTitle":1521,"status":84,"phases":1522,"primaryCompletion":985,"completion":985,"start":1523,"enrollment":27,"conditions":1524,"interventions":1526},"NCT02493959","Degradation of the Anorexic Hormone Peptide YY",[48],"2014-05",[1525],"Healthy",[1515,1527,1528],"PYY1-36 + sitagliptin","PYY3-36",{"trials":1530,"activeCount":74},[],{"trials":1532,"activeCount":74},[],{"trials":1534,"activeCount":74},[],{"trials":1536,"activeCount":74},[],{"trials":1538,"activeCount":74},[],{"intervention":1527,"totalTrials":71,"cells":1540},{"EARLY_PHASE1":1541,"PHASE1":1547,"PHASE2":1549,"PHASE3":1551,"PHASE4":1553,"NA":1555},{"trials":1542,"activeCount":74},[1543],{"nctId":1520,"briefTitle":1521,"status":84,"phases":1544,"primaryCompletion":985,"completion":985,"start":1523,"enrollment":27,"conditions":1545,"interventions":1546},[48],[1525],[1515,1527,1528],{"trials":1548,"activeCount":74},[],{"trials":1550,"activeCount":74},[],{"trials":1552,"activeCount":74},[],{"trials":1554,"activeCount":74},[],{"trials":1556,"activeCount":74},[],{"intervention":1528,"totalTrials":71,"cells":1558},{"EARLY_PHASE1":1559,"PHASE1":1565,"PHASE2":1567,"PHASE3":1569,"PHASE4":1571,"NA":1573},{"trials":1560,"activeCount":74},[1561],{"nctId":1520,"briefTitle":1521,"status":84,"phases":1562,"primaryCompletion":985,"completion":985,"start":1523,"enrollment":27,"conditions":1563,"interventions":1564},[48],[1525],[1515,1527,1528],{"trials":1566,"activeCount":74},[],{"trials":1568,"activeCount":74},[],{"trials":1570,"activeCount":74},[],{"trials":1572,"activeCount":74},[],{"trials":1574,"activeCount":74},[],{"intervention":322,"totalTrials":56,"cells":1576},{"EARLY_PHASE1":1577,"PHASE1":1579,"PHASE2":1581,"PHASE3":1583,"PHASE4":1585,"NA":1595},{"trials":1578,"activeCount":74},[],{"trials":1580,"activeCount":74},[],{"trials":1582,"activeCount":74},[],{"trials":1584,"activeCount":74},[],{"trials":1586,"activeCount":74},[1587,1591],{"nctId":311,"briefTitle":312,"status":84,"phases":1588,"completion":314,"start":315,"enrollment":316,"conditions":1589,"interventions":1590},[52],[318,319,320],[322,323,286],{"nctId":325,"briefTitle":326,"status":224,"phases":1592,"primaryCompletion":328,"completion":329,"start":330,"enrollment":331,"conditions":1593,"interventions":1594},[52],[306],[322,286],{"trials":1596,"activeCount":74},[1597],{"nctId":1598,"briefTitle":1599,"status":84,"phases":1600,"primaryCompletion":1601,"completion":1601,"start":1602,"enrollment":1603,"conditions":1604,"interventions":1606},"NCT02060318","Regulatory T-cells and Crohn's Disease",[],"2016-03-07","2014-02-11",47,[1605],"Crohn Disease",[322],{"intervention":1608,"totalTrials":11,"cells":1609},"Vitamin D",{"EARLY_PHASE1":1610,"PHASE1":1612,"PHASE2":1614,"PHASE3":1616,"PHASE4":1618,"NA":1631},{"trials":1611,"activeCount":74},[],{"trials":1613,"activeCount":74},[],{"trials":1615,"activeCount":74},[],{"trials":1617,"activeCount":74},[],{"trials":1619,"activeCount":74},[1620],{"nctId":1621,"briefTitle":1622,"status":84,"phases":1623,"primaryCompletion":528,"completion":1624,"start":1625,"enrollment":1626,"conditions":1627,"interventions":1630},"NCT00497900","The Effect of Calcium and Vitamin D in Patients With Heart Failure",[52],"2011-12","2007-08",45,[1628,1629],"Heart Failure","Vitamin D Deficiency",[1608],{"trials":1632,"activeCount":74},[1633],{"nctId":1634,"briefTitle":1635,"status":84,"phases":1636,"primaryCompletion":1637,"completion":470,"start":1638,"enrollment":227,"conditions":1639,"interventions":1641},"NCT00990678","Study of Vitamin D Supplementation to Male HIV Sero-positive Patients",[53],"2010-02","2008-04",[1640],"HIV Seropositive",[1642,1608,1643],"Rocaltrol","Calcium",{"intervention":404,"totalTrials":11,"cells":1645},{"EARLY_PHASE1":1646,"PHASE1":1648,"PHASE2":1650,"PHASE3":1652,"PHASE4":1654,"NA":1660},{"trials":1647,"activeCount":74},[],{"trials":1649,"activeCount":74},[],{"trials":1651,"activeCount":74},[],{"trials":1653,"activeCount":74},[],{"trials":1655,"activeCount":74},[1656],{"nctId":394,"briefTitle":395,"status":84,"phases":1657,"primaryCompletion":397,"completion":397,"start":398,"enrollment":227,"conditions":1658,"interventions":1659},[52],[400,401,402],[404,381,404],{"trials":1661,"activeCount":74},[1662],{"nctId":1663,"briefTitle":1664,"status":898,"phases":1665,"primaryCompletion":1666,"completion":1426,"start":528,"enrollment":1053,"conditions":1667,"interventions":1669},"NCT01535781","Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?",[53],"2014-06",[26,1668],"Anemia",[404],{"intervention":1671,"totalTrials":11,"cells":1672},"Saline",{"EARLY_PHASE1":1673,"PHASE1":1675,"PHASE2":1677,"PHASE3":1679,"PHASE4":1681,"NA":1683},{"trials":1674,"activeCount":74},[],{"trials":1676,"activeCount":74},[],{"trials":1678,"activeCount":74},[],{"trials":1680,"activeCount":74},[],{"trials":1682,"activeCount":74},[],{"trials":1684,"activeCount":74},[1685,1694],{"nctId":1686,"briefTitle":1687,"status":84,"phases":1688,"primaryCompletion":1689,"completion":1405,"start":901,"enrollment":24,"conditions":1690,"interventions":1692},"NCT00612625","Near Normalisation of BG Improves the Potentiating Effect of GLP-1",[53],"2004-07",[1691],"Diabetes Mellitus Type 2",[1693,1671],"glucagon-like peptide-1",{"nctId":1695,"briefTitle":1696,"status":84,"phases":1697,"primaryCompletion":1698,"completion":688,"start":663,"enrollment":27,"conditions":1699,"interventions":1700},"NCT00612950","Beta-Cell Function After Near-Normalisation of Blood Glucose",[53],"2007-02",[23],[1701,1702,1671],"glucagon-like peptide-1,","glucose dependent insulinotropic polypeptide",{"intervention":1642,"totalTrials":71,"cells":1704},{"EARLY_PHASE1":1705,"PHASE1":1707,"PHASE2":1709,"PHASE3":1711,"PHASE4":1713,"NA":1715},{"trials":1706,"activeCount":74},[],{"trials":1708,"activeCount":74},[],{"trials":1710,"activeCount":74},[],{"trials":1712,"activeCount":74},[],{"trials":1714,"activeCount":74},[],{"trials":1716,"activeCount":74},[1717],{"nctId":1634,"briefTitle":1635,"status":84,"phases":1718,"primaryCompletion":1637,"completion":470,"start":1638,"enrollment":227,"conditions":1719,"interventions":1720},[53],[1640],[1642,1608,1643],{"intervention":1643,"totalTrials":71,"cells":1722},{"EARLY_PHASE1":1723,"PHASE1":1725,"PHASE2":1727,"PHASE3":1729,"PHASE4":1731,"NA":1733},{"trials":1724,"activeCount":74},[],{"trials":1726,"activeCount":74},[],{"trials":1728,"activeCount":74},[],{"trials":1730,"activeCount":74},[],{"trials":1732,"activeCount":74},[],{"trials":1734,"activeCount":74},[1735],{"nctId":1634,"briefTitle":1635,"status":84,"phases":1736,"primaryCompletion":1637,"completion":470,"start":1638,"enrollment":227,"conditions":1737,"interventions":1738},[53],[1640],[1642,1608,1643],{"intervention":1740,"totalTrials":71,"cells":1741},"Biochemical analysis of different bone markers.",{"EARLY_PHASE1":1742,"PHASE1":1744,"PHASE2":1746,"PHASE3":1748,"PHASE4":1750,"NA":1752},{"trials":1743,"activeCount":74},[],{"trials":1745,"activeCount":74},[],{"trials":1747,"activeCount":74},[],{"trials":1749,"activeCount":74},[],{"trials":1751,"activeCount":74},[],{"trials":1753,"activeCount":74},[1754],{"nctId":1755,"briefTitle":1756,"status":224,"phases":1757,"primaryCompletion":1758,"completion":1759,"start":1760,"enrollment":1125,"conditions":1761,"interventions":1763},"NCT04181164","Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)",[],"2021-09-30","2021-12-30","2019-10-01",[1762],"Hypophosphatasia (HPP)",[1740],{"intervention":1765,"totalTrials":71,"cells":1766},"Indocyanine green",{"EARLY_PHASE1":1767,"PHASE1":1769,"PHASE2":1771,"PHASE3":1773,"PHASE4":1775,"NA":1777},{"trials":1768,"activeCount":74},[],{"trials":1770,"activeCount":74},[],{"trials":1772,"activeCount":74},[],{"trials":1774,"activeCount":74},[],{"trials":1776,"activeCount":74},[],{"trials":1778,"activeCount":74},[1779],{"nctId":1780,"briefTitle":1781,"status":84,"phases":1782,"primaryCompletion":1783,"completion":1783,"start":1784,"enrollment":158,"conditions":1785,"interventions":1788},"NCT02344654","Fluorescence Cholangiography During Cholecystectomy - a RCT",[53],"2018-08-27","2015-05-01",[1786,1787],"Cholecystitis","Gallstones",[1765,1789],"Urografin",{"intervention":1789,"totalTrials":71,"cells":1791},{"EARLY_PHASE1":1792,"PHASE1":1794,"PHASE2":1796,"PHASE3":1798,"PHASE4":1800,"NA":1802},{"trials":1793,"activeCount":74},[],{"trials":1795,"activeCount":74},[],{"trials":1797,"activeCount":74},[],{"trials":1799,"activeCount":74},[],{"trials":1801,"activeCount":74},[],{"trials":1803,"activeCount":74},[1804],{"nctId":1780,"briefTitle":1781,"status":84,"phases":1805,"primaryCompletion":1783,"completion":1783,"start":1784,"enrollment":158,"conditions":1806,"interventions":1807},[53],[1786,1787],[1765,1789],{"intervention":1809,"totalTrials":71,"cells":1810},"Calcium, Dietary",{"EARLY_PHASE1":1811,"PHASE1":1813,"PHASE2":1815,"PHASE3":1817,"PHASE4":1819,"NA":1821},{"trials":1812,"activeCount":74},[],{"trials":1814,"activeCount":74},[],{"trials":1816,"activeCount":74},[],{"trials":1818,"activeCount":74},[],{"trials":1820,"activeCount":74},[],{"trials":1822,"activeCount":74},[1823],{"nctId":1824,"briefTitle":1825,"status":84,"phases":1826,"primaryCompletion":166,"completion":1827,"start":482,"enrollment":1828,"conditions":1829,"interventions":1832},"NCT01141998","Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption",[53],"2011-03",27,[1830,1831],"Chronic Pancreatitis","Malabsorption Syndromes",[1809,1833,1833],"Cholecalciferol",{"intervention":1833,"totalTrials":71,"cells":1835},{"EARLY_PHASE1":1836,"PHASE1":1838,"PHASE2":1840,"PHASE3":1842,"PHASE4":1844,"NA":1846},{"trials":1837,"activeCount":74},[],{"trials":1839,"activeCount":74},[],{"trials":1841,"activeCount":74},[],{"trials":1843,"activeCount":74},[],{"trials":1845,"activeCount":74},[],{"trials":1847,"activeCount":74},[1848],{"nctId":1824,"briefTitle":1825,"status":84,"phases":1849,"primaryCompletion":166,"completion":1827,"start":482,"enrollment":1828,"conditions":1850,"interventions":1851},[53],[1830,1831],[1809,1833,1833],{"intervention":1693,"totalTrials":71,"cells":1853},{"EARLY_PHASE1":1854,"PHASE1":1856,"PHASE2":1858,"PHASE3":1860,"PHASE4":1862,"NA":1864},{"trials":1855,"activeCount":74},[],{"trials":1857,"activeCount":74},[],{"trials":1859,"activeCount":74},[],{"trials":1861,"activeCount":74},[],{"trials":1863,"activeCount":74},[],{"trials":1865,"activeCount":74},[1866],{"nctId":1686,"briefTitle":1687,"status":84,"phases":1867,"primaryCompletion":1689,"completion":1405,"start":901,"enrollment":24,"conditions":1868,"interventions":1869},[53],[1691],[1693,1671],{"intervention":1871,"totalTrials":71,"cells":1872},"exendin 9-39",{"EARLY_PHASE1":1873,"PHASE1":1875,"PHASE2":1877,"PHASE3":1879,"PHASE4":1881,"NA":1883},{"trials":1874,"activeCount":74},[],{"trials":1876,"activeCount":74},[],{"trials":1878,"activeCount":74},[],{"trials":1880,"activeCount":74},[],{"trials":1882,"activeCount":74},[],{"trials":1884,"activeCount":74},[1885],{"nctId":1886,"briefTitle":1887,"status":84,"phases":1888,"primaryCompletion":609,"completion":98,"start":1889,"enrollment":99,"conditions":1890,"interventions":1891},"NCT02336659","Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery",[53],"2014-04",[90],[1871,1892],"sitagliptin",{"intervention":1892,"totalTrials":71,"cells":1894},{"EARLY_PHASE1":1895,"PHASE1":1897,"PHASE2":1899,"PHASE3":1901,"PHASE4":1903,"NA":1905},{"trials":1896,"activeCount":74},[],{"trials":1898,"activeCount":74},[],{"trials":1900,"activeCount":74},[],{"trials":1902,"activeCount":74},[],{"trials":1904,"activeCount":74},[],{"trials":1906,"activeCount":74},[1907],{"nctId":1886,"briefTitle":1887,"status":84,"phases":1908,"primaryCompletion":609,"completion":98,"start":1889,"enrollment":99,"conditions":1909,"interventions":1910},[53],[90],[1871,1892],{"intervention":1912,"totalTrials":71,"cells":1913},"Insulin Aspart",{"EARLY_PHASE1":1914,"PHASE1":1916,"PHASE2":1918,"PHASE3":1920,"PHASE4":1922,"NA":1924},{"trials":1915,"activeCount":74},[],{"trials":1917,"activeCount":74},[],{"trials":1919,"activeCount":74},[],{"trials":1921,"activeCount":74},[],{"trials":1923,"activeCount":74},[],{"trials":1925,"activeCount":74},[1926],{"nctId":1927,"briefTitle":1928,"status":84,"phases":1929,"primaryCompletion":166,"completion":166,"start":145,"enrollment":99,"conditions":1930,"interventions":1931},"NCT01223560","Collection of Information-Rich Type 1 Diabetes Data",[53],[21],[1912],{"intervention":1933,"totalTrials":71,"cells":1934},"Dobutamine",{"EARLY_PHASE1":1935,"PHASE1":1937,"PHASE2":1939,"PHASE3":1941,"PHASE4":1943,"NA":1945},{"trials":1936,"activeCount":74},[],{"trials":1938,"activeCount":74},[],{"trials":1940,"activeCount":74},[],{"trials":1942,"activeCount":74},[],{"trials":1944,"activeCount":74},[],{"trials":1946,"activeCount":74},[1947],{"nctId":1948,"briefTitle":1949,"status":84,"phases":1950,"completion":1379,"start":1951,"conditions":1952,"interventions":1954},"NCT00250315","DOCICAR: Cardiac Dysfunction in Cirrhosis",[],"2005-11",[31,1953],"Cirrhotic Cardiomyopathy",[1933],{"intervention":1956,"totalTrials":71,"cells":1957},"injection with the stromal vascular fraction (SVF) of adipose tissue",{"EARLY_PHASE1":1958,"PHASE1":1960,"PHASE2":1962,"PHASE3":1964,"PHASE4":1966,"NA":1968},{"trials":1959,"activeCount":74},[],{"trials":1961,"activeCount":74},[],{"trials":1963,"activeCount":74},[],{"trials":1965,"activeCount":74},[],{"trials":1967,"activeCount":74},[],{"trials":1969,"activeCount":74},[1970],{"nctId":1971,"briefTitle":1972,"status":84,"phases":1973,"primaryCompletion":97,"completion":97,"start":1974,"enrollment":637,"conditions":1975,"interventions":1978},"NCT02697682","Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study",[53],"2016-03",[1976,1977],"Osteoarthritis","Stem Cells",[1956],{"intervention":1980,"totalTrials":71,"cells":1981},"metformin",{"EARLY_PHASE1":1982,"PHASE1":1984,"PHASE2":1986,"PHASE3":1988,"PHASE4":1990,"NA":1992},{"trials":1983,"activeCount":74},[],{"trials":1985,"activeCount":74},[],{"trials":1987,"activeCount":74},[],{"trials":1989,"activeCount":74},[],{"trials":1991,"activeCount":74},[],{"trials":1993,"activeCount":74},[1994],{"nctId":1995,"briefTitle":1996,"status":898,"phases":1997,"primaryCompletion":662,"completion":662,"start":901,"enrollment":1998,"conditions":1999,"interventions":2001},"NCT00647023","Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)",[53],66,[2000],"Polycystic Ovary Syndrome",[1980],{"intervention":2003,"totalTrials":71,"cells":2004},"Dexamethasone",{"EARLY_PHASE1":2005,"PHASE1":2007,"PHASE2":2009,"PHASE3":2011,"PHASE4":2013,"NA":2015},{"trials":2006,"activeCount":74},[],{"trials":2008,"activeCount":74},[],{"trials":2010,"activeCount":74},[],{"trials":2012,"activeCount":74},[],{"trials":2014,"activeCount":74},[],{"trials":2016,"activeCount":74},[2017],{"nctId":2018,"briefTitle":2019,"status":84,"phases":2020,"primaryCompletion":1666,"start":167,"enrollment":2021,"conditions":2022,"interventions":2023},"NCT02235584","Insulinotropic Effect of GLP-1 and GIP After Dexamethasone",[53],19,[23],[2003],{"intervention":2025,"totalTrials":71,"cells":2026},"autologous, micro-fragmented adipose tissue",{"EARLY_PHASE1":2027,"PHASE1":2029,"PHASE2":2031,"PHASE3":2033,"PHASE4":2035,"NA":2037},{"trials":2028,"activeCount":74},[],{"trials":2030,"activeCount":74},[],{"trials":2032,"activeCount":74},[],{"trials":2034,"activeCount":74},[],{"trials":2036,"activeCount":74},[],{"trials":2038,"activeCount":74},[2039],{"nctId":2040,"briefTitle":2041,"status":224,"phases":2042,"primaryCompletion":2043,"completion":2044,"start":2045,"enrollment":158,"conditions":2046,"interventions":2048},"NCT03771989","Treatment of Osteoarthritis With Autologous, Microfragmented Adipose Tissue.",[53],"2022-02-28","2024-03-30","2019-01-01",[2047],"Osteoarthritis, Knee",[2025],{"intervention":2050,"totalTrials":71,"cells":2051},"Thrombelastography analysis",{"EARLY_PHASE1":2052,"PHASE1":2054,"PHASE2":2056,"PHASE3":2058,"PHASE4":2060,"NA":2062},{"trials":2053,"activeCount":74},[],{"trials":2055,"activeCount":74},[],{"trials":2057,"activeCount":74},[],{"trials":2059,"activeCount":74},[],{"trials":2061,"activeCount":74},[],{"trials":2063,"activeCount":74},[2064],{"nctId":2065,"briefTitle":2066,"status":84,"phases":2067,"primaryCompletion":1523,"completion":1426,"start":1051,"enrollment":2068,"conditions":2069,"interventions":2070},"NCT02297061","Can Thrombelastography Predict Blood Loss in Patients With Hip Fractures",[],180,[26,400],[2050],{"intervention":2072,"totalTrials":71,"cells":2073},"Cefuroxime",{"EARLY_PHASE1":2074,"PHASE1":2076,"PHASE2":2078,"PHASE3":2080,"PHASE4":2082,"NA":2084},{"trials":2075,"activeCount":74},[],{"trials":2077,"activeCount":74},[],{"trials":2079,"activeCount":74},[],{"trials":2081,"activeCount":74},[],{"trials":2083,"activeCount":74},[],{"trials":2085,"activeCount":74},[2086],{"nctId":2087,"briefTitle":2088,"status":224,"phases":2089,"start":2090,"enrollment":2091,"conditions":2092,"interventions":2097},"NCT00162604","Prophylactic Antibiotic Treatment During Vaginal Repair",[53],"2005-05",200,[2093,2094,2095,2096],"Uterine Prolapse","Cystocele","Rectocele","Enterocele",[2072],{"intervention":2099,"totalTrials":71,"cells":2100},"Glucagon before exercise",{"EARLY_PHASE1":2101,"PHASE1":2103,"PHASE2":2105,"PHASE3":2107,"PHASE4":2109,"NA":2111},{"trials":2102,"activeCount":74},[],{"trials":2104,"activeCount":74},[],{"trials":2106,"activeCount":74},[],{"trials":2108,"activeCount":74},[],{"trials":2110,"activeCount":74},[],{"trials":2112,"activeCount":74},[2113],{"nctId":2114,"briefTitle":2115,"status":84,"phases":2116,"primaryCompletion":2117,"completion":2117,"start":2118,"enrollment":2119,"conditions":2120,"interventions":2122},"NCT02882737","The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus",[53],"2017-07-11","2016-09",14,[2121],"Type 1 Diabetes Mellitus",[2099,2123,2124],"Glucagon after exercise","Glucagon after resting",{"intervention":2123,"totalTrials":71,"cells":2126},{"EARLY_PHASE1":2127,"PHASE1":2129,"PHASE2":2131,"PHASE3":2133,"PHASE4":2135,"NA":2137},{"trials":2128,"activeCount":74},[],{"trials":2130,"activeCount":74},[],{"trials":2132,"activeCount":74},[],{"trials":2134,"activeCount":74},[],{"trials":2136,"activeCount":74},[],{"trials":2138,"activeCount":74},[2139],{"nctId":2114,"briefTitle":2115,"status":84,"phases":2140,"primaryCompletion":2117,"completion":2117,"start":2118,"enrollment":2119,"conditions":2141,"interventions":2142},[53],[2121],[2099,2123,2124],{"intervention":2124,"totalTrials":71,"cells":2144},{"EARLY_PHASE1":2145,"PHASE1":2147,"PHASE2":2149,"PHASE3":2151,"PHASE4":2153,"NA":2155},{"trials":2146,"activeCount":74},[],{"trials":2148,"activeCount":74},[],{"trials":2150,"activeCount":74},[],{"trials":2152,"activeCount":74},[],{"trials":2154,"activeCount":74},[],{"trials":2156,"activeCount":74},[2157],{"nctId":2114,"briefTitle":2115,"status":84,"phases":2158,"primaryCompletion":2117,"completion":2117,"start":2118,"enrollment":2119,"conditions":2159,"interventions":2160},[53],[2121],[2099,2123,2124],{"intervention":2162,"totalTrials":71,"cells":2163},"Adrenaline",{"EARLY_PHASE1":2164,"PHASE1":2166,"PHASE2":2168,"PHASE3":2170,"PHASE4":2172,"NA":2174},{"trials":2165,"activeCount":74},[],{"trials":2167,"activeCount":74},[],{"trials":2169,"activeCount":74},[],{"trials":2171,"activeCount":74},[],{"trials":2173,"activeCount":74},[],{"trials":2175,"activeCount":74},[2176],{"nctId":2177,"briefTitle":2178,"status":84,"phases":2179,"completion":2180,"start":2181,"enrollment":2182,"conditions":2183,"interventions":2186},"NCT00322660","Adrenaline Injections to Children Born at Elective CS",[53],"2007-06","2006-06",270,[2184,2185],"Respiratory Distress","Hypoglycemia",[2162],{"intervention":1701,"totalTrials":71,"cells":2188},{"EARLY_PHASE1":2189,"PHASE1":2191,"PHASE2":2193,"PHASE3":2195,"PHASE4":2197,"NA":2199},{"trials":2190,"activeCount":74},[],{"trials":2192,"activeCount":74},[],{"trials":2194,"activeCount":74},[],{"trials":2196,"activeCount":74},[],{"trials":2198,"activeCount":74},[],{"trials":2200,"activeCount":74},[2201],{"nctId":1695,"briefTitle":1696,"status":84,"phases":2202,"primaryCompletion":1698,"completion":688,"start":663,"enrollment":27,"conditions":2203,"interventions":2204},[53],[23],[1701,1702,1671],{"intervention":1702,"totalTrials":71,"cells":2206},{"EARLY_PHASE1":2207,"PHASE1":2209,"PHASE2":2211,"PHASE3":2213,"PHASE4":2215,"NA":2217},{"trials":2208,"activeCount":74},[],{"trials":2210,"activeCount":74},[],{"trials":2212,"activeCount":74},[],{"trials":2214,"activeCount":74},[],{"trials":2216,"activeCount":74},[],{"trials":2218,"activeCount":74},[2219],{"nctId":1695,"briefTitle":1696,"status":84,"phases":2220,"primaryCompletion":1698,"completion":688,"start":663,"enrollment":27,"conditions":2221,"interventions":2222},[53],[23],[1701,1702,1671],{"intervention":2224,"totalTrials":71,"cells":2225},"Clopidogrel",{"EARLY_PHASE1":2226,"PHASE1":2228,"PHASE2":2230,"PHASE3":2232,"PHASE4":2234,"NA":2236},{"trials":2227,"activeCount":74},[],{"trials":2229,"activeCount":74},[],{"trials":2231,"activeCount":74},[],{"trials":2233,"activeCount":74},[],{"trials":2235,"activeCount":74},[],{"trials":2237,"activeCount":74},[2238],{"nctId":2239,"briefTitle":2240,"status":84,"phases":2241,"primaryCompletion":1051,"completion":1107,"start":470,"enrollment":2242,"conditions":2243,"interventions":2244},"NCT02391883","Hip-Fracture Surgery on Patients in Clopidogrel Therapy",[],356,[26],[2224]]